X0306 4 2022-08-17 0 0001348911 KalVista Pharmaceuticals, Inc. KALV 0001691090 Feener Edward P. C/O KALVISTA PHARMACEUTICALS, INC. 55 CAMBRIDGE PARKWAY, SUITE 901E CAMBRIDGE MA 02142 0 1 0 0 Chief Scientific Officer Common Stock 2022-08-17 4 M 0 1773 A 61664 D Common Stock 2022-08-17 4 S 0 532 14.9619 D 61132 D Restricted Stock Unit 2022-08-17 4 M 0 1773 0.00 D Common Stock 1773 26607 D Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's Class A Common Stock upon settlement for no consideration. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.96 to $15.1297, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. 1/16th of the total restricted stock units subject to the Award shall vest on each quarterly anniversary of the Vesting Commencement Date thereafter, subject to continued service through each vesting date. /s/ Benjamin L. Palleiko, Attorney-in-Fact 2022-08-19